Gongboy, I think the key points here are:
(1) sleep apnoea is a severely un-diagnosed condition
(2) despite this Resmed have built a marvellous business with a stellar $22b market cap
(3) Current sleep labortory diagnosis is expensive $1000 - $2000, and inconvenient - as you need to sleep the night at a designated lab., and even then the test can fail requiring a repeat
(4) So far, Resapp can diagnose sleep apnoea with 80-82% sensitivity and specificity (I say so far because it is early days and i expect over time this will get better)
(5) That is a very high accuracy and very cheap and convenient, and can be repeated many times
(6) Seems clear to me this tech would be very useful to increase diagnosis for Resmed or any competitors to grow market share.
(7) have a look at the pictures below (I know using the Rap device wont make you 30 years younger but you see what I mean)
(8) Compare accuracy, convenience, cost and repeatability - Resmed should takeover or licence this tech before their competitors do.
V's
- Forums
- ASX - By Stock
- Sleep apnea detection
Gongboy, I think the key points here are: (1) sleep apnoea is a...
Add RMD (ASX) to my watchlist
(20min delay)
|
|||||
Last
$37.28 |
Change
0.200(0.54%) |
Mkt cap ! $22.38B |
Open | High | Low | Value | Volume |
$37.50 | $37.55 | $37.15 | $17.93M | 480.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3363 | $37.27 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$37.30 | 1001 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 13767 | 14.400 |
2 | 17668 | 14.390 |
3 | 20967 | 14.380 |
2 | 14124 | 14.370 |
4 | 21382 | 14.360 |
Price($) | Vol. | No. |
---|---|---|
14.430 | 22863 | 3 |
14.440 | 27216 | 4 |
14.450 | 46627 | 8 |
14.460 | 34563 | 7 |
14.470 | 22668 | 7 |
Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
RMD (ASX) Chart |